BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

ProSensa Holding N.V. 

Wassenaarseweg 72

Leiden    2333 AL  The Netherlands
Phone: 31-71-5274202 Fax: 31-71-5274203


SEARCH JOBS


Industry
Biotechnology






 Company News
ProSensa Holding N.V. (RNA) To Appoint Michael Wyzga To Supervisory Board 4/8/2014 7:33:38 AM    More...
ProSensa Holding N.V. (RNA) Announces Full Year 2013 Financial Results And Recent Corporate Developments 3/18/2014 9:01:23 AM    More...
ProSensa Holding N.V. (RNA) Announces 48-Week Data From A U.S. Phase 2 Placebo-Controlled Study Of Drisapersen In 51 DMD Boys 3/18/2014 8:53:09 AM    More...
ProSensa Holding N.V. (RNA) To Present At Upcoming Investor Conferences 3/6/2014 9:37:01 AM    More...
ProSensa Holding N.V. (RNA) To Webcast Conference Call Discussing Full Year 2013 Financial Results And Corporate Update On March 18, 2014 3/5/2014 9:17:58 AM    More...
ProSensa Holding N.V. (RNA) To Participate At Upcoming Investor Conferences 1/31/2014 9:07:25 AM    More...
ProSensa Holding N.V. (RNA) Reports Initial Findings From The Further Clinical Data Analyses Of Drisapersen For The Treatment Of Duchenne Muscular Dystrophy 1/16/2014 11:27:11 AM    More...
ProSensa Holding N.V. (RNA) To Provide Corporate Update To Key Stakeholders 1/14/2014 9:27:09 AM    More...
GlaxoSmithKline (GSK) Hands Back Failed Duchenne Muscular Dystrophy (DMD) To ProSensa Holding N.V. (RNA) 1/13/2014 7:02:52 AM    More...
ProSensa Holding N.V. (RNA) To Present Corporate Overview At The 32nd Annual J.P. Morgan Healthcare Conference 1/7/2014 9:11:11 AM    More...
12345

//-->